Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Vanda Pharmaceuticals Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 181 | 3 | 182 | +4 |
| Shares | 54.9M | 276.1K | 55.2M | +660.7K (+1.2%) |
| Value | $1.18B | $5.94M | $946.9M | −$226.3M (−19.3%) |
3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Soleus Capital Management, L.P. | 298,600 | $5.12M | 0.80% |
| Pictet Asset Management SA | 247,636 | $4.24M | 0.00% |
| Denali Advisors LLC | 89,300 | $1.53M | 0.64% |
| First Trust Advisors LP | 80,295 | $1.38M | 0.00% |
| Healthcare of Ontario Pension Plan Trust Fund | 79,100 | $1.36M | 0.00% |
| SG Americas Securities, LLC | 71,320 | $1.22M | 0.01% |
| Franklin Resources Inc | 31,897 | $546.0K | 0.00% |
| Robeco Institutional Asset Management B.V. | 25,905 | $444.0K | 0.00% |
| Maryland State Retirement & Pension System | 21,817 | $382.0K | 0.01% |
| Grantham, Mayo, Van Otterloo & Co. LLC | 13,100 | $225.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 10,000 | $172.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5,736 | $98.0K | 0.00% |
| Point72 Hong Kong Ltd | 711 | $12.0K | 0.00% |
| Lake Point Wealth Management | 460 | $8.00K | 0.00% |
| Fifth Third Bancorp | 114 | $2.00K | 0.00% |
| Carroll Financial Associates, Inc. | 109 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 46 | $1.00K | 0.00% |
| Liberty Wealth Management LLC | 25 | $0 | 0.00% |
| Kowal Investment Group, LLC | 2 | $0 | 0.00% |
Sold out (15)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| PDT Partners, LLC | 57,998 | $1.25M |
| Maverick Capital LtdSuperinvestorMaverick Capital | 47,091 | $1.01M |
| Exchange Traded Concepts, LLC | 35,187 | $757.0K |
| Avidian Wealth Solutions, LLC | 18,000 | $387.0K |
| HRT Financial LP | 17,571 | $377.0K |
| ExodusPoint Capital Management, LP | 17,034 | $366.0K |
| Ci Investments Inc. | 14,193 | $305.0K |
| 6 Meridian | 13,607 | $293.0K |
| Hancock Whitney Corp | 13,156 | $282.0K |
| Profund Advisors LLC | 10,855 | $231.0K |
| FORA Capital, LLC | 5,990 | $129.0K |
| Altshuler Shaham Ltd | 5,811 | $125.0K |
| C M Bidwell & Associates Ltd | 2,510 | $54.0K |
| Newbridge Financial Services Group, Inc. | 1,400 | $30.0K |
| TCI Wealth Advisors, Inc. | 137 | $3.00K |
Not filed for Q3 2021 yet (3)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 247,538 | $5.33M |
| QS Investors, LLC | 28,500 | $614.0K |
| CWM, LLC | 41 | $1.00K |